Catalyst Brief

← Calendar

Readoutin 75d

ModernaTX, Inc. — mRNA-1403

Phase 3 primary completion: A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis.

Date
Feb 2027
Type
Readout
Indication
Acute Gastroenteritis

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.

More from ModernaTX, Inc.

  1. Jan2027